Related Experiment Video
Updated: Jan 31, 2026
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Osteoporosis in inflammatory bowel disease
Patients with inflammatory bowel disease (IBD) face higher risks of osteoporosis and fractures. Bisphosphonate treatment shows promise for improving bone density and reducing fracture risk in these individuals.
Area of Science:
- Gastroenterology and Bone Metabolism
Background:
- Inflammatory bowel disease (IBD) patients have elevated risks for osteoporosis and fractures.
- Risk factors include intestinal inflammation, nutrient deficiencies, corticosteroid use, age, gender, and BMI.
- The aging IBD patient population necessitates proactive bone health management.
Purpose of the Study:
- To evaluate the efficacy and safety of bisphosphonate therapy for osteoporosis in IBD patients.
- To highlight the importance of managing bone health in IBD for improving quality of life.
Main Methods:
- A meta-analysis was conducted to assess bisphosphonate's effectiveness.
- Data on bone mineral density and fracture risk reduction were analyzed.
Main Results:
- Bisphosphonate therapy is effective and safe for treating low bone mineral density in IBD patients.
- Bisphosphonates significantly reduce the risk of vertebral fractures in this population.
Conclusions:
- Bisphosphonates are a viable treatment option for osteoporosis in IBD.
- Effective management of osteoporosis is crucial for enhancing the quality of life for IBD patients, especially with an increasing elderly demographic.
More Related Videos
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:28Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...